Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2009 Apr 1.
Published in final edited form as: Genet Res (Camb). 2008 Oct;90(5):433–444. doi: 10.1017/S0016672308009798

Genetic Relationships between Obesity and Osteoporosis in LGXSM Recombinant Inbred Mice

Michael S Reich 1, Joseph P Jarvis 1, Matthew J Silva 2, James M Cheverud 1,*
PMCID: PMC2649827  NIHMSID: NIHMS89333  PMID: 19061533

Summary

Obesity and osteoporosis affect millions of Americans. While phenotypically, obesity is negatively correlated with fracture risk, research on a genetic basis for this relationship is lacking. We used males and females from 16 LGXSM recombinant inbred (RI) mouse strains to investigate the genetically-mediated relationship between obesity and osteoporosis-related traits. First, heritabilities were estimated for (1) bone morphological properties determined by microCT (femoral and radial diaphyseal bone cross-sectional area and moments of inertia, as well as proximal tibial trabecular bone volume, connectivity density, structure model index, trabecular number, trabecular thickness, and trabecular separation), (2) mechanical properties determined by bending tests (femoral and radial rigidity, yield moment, ultimate moment, fracture displacement, and post-yield displacement), and (3) effective material properties (femoral and radial modulus of elasticity and ultimate tensile strength). All femoral (H2: 43-74%) and tibial traits (H2: 31-56%) were heritable; as were eight of 10 radial traits (H2: 21-33%). Eighteen significant genetic correlations were discovered between obesity- and osteoporosis-related phenotypes. Genetic correlations indicate that gene effects associated with increased fat mass and leptin levels are also associated with larger, stronger femora. Gene effects associated with larger, stronger radii and with denser tibiae were also associated with increased fat mass but not with leptin levels. Furthermore, quantitative trait loci (QTLs) previously reported for obesity and leptin levels also had effects on bone morphology, mechanical, and material properties. Our results support the use of the LG/J x SM/J mouse intercross populations as models for normal, complex genetic variation in obesity, bone properties, and their interrelationship.

Keywords: Quantitative Genetics, obesity, osteoporosis, LGXSM mouse strains

1. Introduction

Both osteoporosis and obesity are serious health concerns that have been increasing in prevalence over the past two decades. Fifty-five percent of individuals of at least 50 years of age have either osteoporosis or osteopenia (National Osteoporosis Foundation, 2002). Obesity is also a common condition in the US population; nearly 66% of US adults aged 20 or older are either overweight or obese (Hedley et al., 2004) based on their body mass index (BMI). Secondary health implications of obesity include an increased incidence of high cholesterol levels, coronary artery disease, gallbladder disease, hypertension, type-II diabetes mellitus, and osteoarthritis (Mokdad et al., 2003; Must et al., 1999).

These two diseases have usually been considered separately but more recently both clinical and molecular linkages between them have become evident (Rosen and Bouxsein, 2006). Epidemiological studies show a positive correlation between BMI and bone mineral density (BMD) in humans (Castro et al., 2005). In addition, positive correlations have been reported between an increase in fat mass and BMD at different skeletal locations in both females and males (Reid et al., 1992; Stewart et al., 2002). However, a twin study suggested that the correlation between BMD and BMI may be primarily due to environmental (rE ∼ 0.60) rather than genetic factors (rG ∼ 0.20) (Nguyen et al., 1998).

One recently delineated physiological link between osteoporosis and obesity occurs via leptin, a hormone produced by adipocytes that serves as a satiety signal, triggering the brain to stop food acquisition and increase metabolism (Halaas et al., 1995; Considine et al., 1996). Interestingly, obese individuals may suffer from hyperleptinemia and leptin resistance (Frederich et al., 1995; Hamrick et al., 2004) resulting in satiety signals not being properly interpreted by the brain and allowing obese individuals to consume more calories than necessary (Frederich et al., 1995). Leptin also affects BMD, having different effects on different skeletal locations. Leptin deficiency in mice leads to shorter femora and decreased femoral BMD, cortical area, and amount of trabecular bone as compared to wildtype controls. In contrast, in vertebrae, leptin deficient mice have increased vertebral length and increased BMD and trabecular bone area (Hamrick et al., 2004). Research also shows increased osteoclast activity in the femora of leptin deficient mice and increased osteoclast activity in the spine of leptin treated mice (Hamrick et al., 2004, 2005). In addition to the role of leptin, there is strong evidence that other adipokines, including adiponectin, also affect bone turnover (Lenchik et al., 2003; Shinoda et al., 2006; Jürimäe and Jürimäe, 2007; Richards et al., 2007) along with other factors, such as neuropeptide Y and neuromedin U, affecting energy metabolism and bone through hypothalamic processing (Allison and Herzog, 2006; Panuccio et al., 2007; Sato et al., 2007).

Several additional factors may affect the relationship between bone and obesity. First, there is the relationship between obesity, mechanical loading, and bone morphology that predicts stronger bones as a result of higher mechanical loading in heavier individuals. Furthermore, bone and fat cells originate from the same progenitor cell populations but develop through alternate, mutually exclusive pathways (Wan et al., 2006). This is indicated in young adult humans where there is an inverse relationship between bone marrow adiposity and the amount of bone in the axial and appendicular skeleton (Iorgi et al., 2008).

Lee et al. (2007) show that osteoblasts also produce factors with substantial effects on metabolism and obesity, through the effects of osteocalcin on the pancreas and other tissues. Bone helps regulate metabolism, and therefore has an effect on obesity. Beta cells and adipocytes were known to regulate bone but it seems that bone is also talking back. (Lee et al., 2007; Semenkovich and Teitelbaum, 2007). Hence, there are a variety of physiological mechanisms connecting bone and obesity with feedback between adipose and osseous tissues.

More general genetic analyses can contribute to our understanding of the relationship between obesity and osteoporosis outside of the single gene leptin deficiency models commonly used in this research. Many quantitative trait loci (QTLs) have been reported separately for obesity- and osteoporosis-related traits. The 2004 Obesity Gene Map Update by Perusse et al. (2005) describes 221 obesity-related quantitative trait loci (QTLs) found in mouse models and 204 QTLs found in human studies. Studies have found loci for obesity-related traits on all human and mouse autosomes and on the X chromosome (Perusse et al., 2005). These genes affect fatness, BMI, body weight (Dionne et al., 2002), insulin levels, and leptin levels (Arya et al., 2002). Studies of mouse models also indicate that bone properties can be affected by many loci. Additionally, QTLs for femoral and vertebral BMD as well as femoral bone area, moment of inertia, rigidity, ultimate moment, and energy to fracture have been found on all mouse chromosomes except chromosomes 3 and 17 (Beamer et al., 1999, 2001; Koller et al., 2003; Klein et al., 2002). We are unaware of genetic studies that have examined the relationships between obesity and osteoporosis in a variable mouse population.

In this report we describe the relative contribution of genetic effects on bone morphology, mechanical, and material properties in relation to obesity-related traits by estimating genetic correlations between obesity- and osteoporosis-related traits in LGXSM recombinant inbred (RI) lines of mice. In addition, Cheverud et al. (2004a) found six fat mass QTLs, four of which also affected leptin levels, in a genome scan of the LGXSM recombinant inbred (RI) lines. Therefore, we will test whether these previously identified obesity and leptin QTLs also affect bone morphology, mechanical, and material properties.

2. Materials and Methods

(i) Specimens

The 16 LGXSM recombinant inbred (RI) strains of mice used in this study were derived from the intercross of LG/J females and SM/J males, obtained from the Jackson Laboratories (Bar Harbor, ME). LG/J and SM/J were developed in the 1940’s and have since been maintained by brother-sister mating. Both strains resulted from artificial selection experiments in which large and small body weight phenotypes were selected (Goodale, 1938, 1941; MacArthur, 1944). Genetic studies on these mice have revealed that the extreme phenotypes result from genotypic differences at many loci of small effect and their interactions (Chai, 1956).

Three males and three females from each RI strain were used in this study (four mice were included for LGXSM 38 females), totaling 97 mice. All mice were between 20.3 and 31.6 weeks old at the time of necropsy (Average = 25 weeks, SD = 2.43), at which point they had already reached skeletal maturity (Ehrich et al., 2003). We detected no effects of age at necropsy on the osseous phenotypes and ages were randomly distributed relative to strain membership. All animals were fed high-fat diets ad libitum as part of a dietary obesity experiment (Cheverud et al. 2004a) (catalog #TD88137, Harlan Teklad, Madison, WI, USA). We first examined animals on a high fat diet because they have more extreme obesity-related trait values and higher levels of interstrain variation than low fat fed animals. Later studies will focus on the effects of dietary fat on bone properties and QTL effects. We used fat mass - a combined measure of reproductive, renal, mesenteric, and inguinal fat pad weights at the time of necropsy - and serum leptin levels obtained from the plasma of blood samples acquired after mice fasted for four hours as obesity-related traits. Fat mass data for one mouse and leptin levels for four mice were not available for this analysis. The average obesity phenotypes for all mice of each sex-strain cohort are provided in Cheverud et al. (2004b) and were used to represent mice of the same sex and strain that lacked fat mass and leptin data. All mice were stored in freezers maintained at -20°C until used in this study.

A single femur, radius, and tibia were removed from each mouse. Most bones were from the right anatomical side, although some were taken from the left when the right side was damaged or unavailable. Bilateral bones are morphologically and mechanically similar to one another and assumed to be interchangeable (Margolis et al., 2004). Due to dissection errors there was no available femur for one mouse, no radius for 10 mice, and no tibia for four mice. Immediately after removal, bones were wrapped in tissue soaked in 0.9% saline solution. Each wet bone was subsequently wrapped in plastic wrap and then placed in a plastic tube and stored in a freezer at -20°C. Bones remained in the freezer until they were required for scanning or mechanical testing.

(ii) Phenotypic data collection

Bone morphology was assessed using micro-computed tomography. In preparation for scanning, bones were thawed at room temperature and embedded in 1.5% agarose gel to ensure moistness and prevent motion. Bones were scanned using a commercial system (μCT 40, SCANCO Medical AG, Bassersdorf, Switzerland) at 16 μm isotropic resolution. Femora and radii were scanned at their mid-diaphysis. Four sets of three slices were taken for each bone; the sets were located ±1.5 mm and ±0.5 mm from the midpoint. These scans were then exported and converted to binary images using a simple threshold midway between the values of bone and background (ImageJ, NIH, Bethesda, MD, USA). Femoral images were rotated such that the medial-lateral bone axis was horizontal (x-axis); this was the bending axis for subsequent mechanical testing. Images of the radii were likewise rotated so that the axis of bending was horizontal. Using a custom macro (Excel; Microsoft Corporation, Redmond, WA, USA), the coordinates of the bone voxels were used to determine bone area (Area) and moments of inertia with respect to the x-axis and y-axis (Ixx and Iyy, respectively). For each morphological property, the average value calculated from the twelve slices of each bone was used for data analysis. Following scanning, femora and radii were placed back into storage at -20°C until mechanical testing.

The morphological properties of tibial trabecular bone were obtained by scanning the proximal region of each tibia. Thirty slices of the metaphysis, spanning 0.48 mm and starting just distal to the growth plate, were used in analysis. Trabecular bone regions were segmented using the SCANCO analysis software’s contouring function and manually corrected to ensure the appropriate regions were enveloped. The regions were analyzed by the software to measure trabecular bone volume per total volume (BV/TV), connectivity density (ConnD), structure model index (SMI), trabecular number (TbN), trabecular thickness (TbTh), and trabecular separation (TbSp).

Mechanical testing on femora and radii was done using a three-point bending test. Prior to mechanical testing, bones were thawed in 0.9% phosphate buffered saline solution. The mid-diaphysis of each bone was then measured and marked. Tests were conducted using an Instron 1331/8500R and 8841 for femora and radii, respectively (Instron Corporation, Canton, MA, USA). The support span (L) for the femora was 7 mm; the span for radii was 8 mm. For both bones, the rate of vertical displacement of the load point was 0.03 mm/sec. The applied force and bone displacement were recorded at 60 Hz using Labview7.0 (National Instruments, Austin, TX, USA). The output from the three-point bending tests was a force (F) versus displacement (d) graph which, by taking into account the span, was converted to a moment (M) versus normalized displacement (d’) graph by the equations (Brodt et al., 1999):

M=(F×L)4
d=d×12L2.

Rigidity (Rig), yield moment (My), ultimate moment (Mu), fracture displacement (d’ fx), and post-yield displacement (d’ py) were calculated from these graphs.

Two material properties were derived from the morphological and mechanical properties of the femur and radius: Young’s modulus, or modulus of elasticity (E), and ultimate tensile strength (σult). These properties were calculated using simple beam theory equations and thus represent estimates rather than direct measures (Brodt et al., 1999; Turner and Burr, 1993):

E=RigIxx
σult=(Mu×Ymax)Ixx

(iii) Statistical analysis

Heritabilities were calculated using the general linear model (GLM) of the statistical program Systat11 (Systat Software, Incorporated, Point Richmond, CA, USA). The GLM function performs analysis of variance (ANOVA) tests. A two-way ANOVA was performed using the model:

Yijk=μ+sexi+strainj+(sexi×strainj)+eijk

where Yijk is the phenotype of the kth animal modeled by the overall phenotypic mean (μ), the deviation from the mean due to the ith sex and the jth strain, the interaction between ith sex and jth strain, and the residual or environmental effect (eijk). Sex was treated as a fixed factor, while strain was considered a random factor (Sokal and Rohlf, 1995). When a group of traits were considered jointly, we used multivariate analysis of variance (MANOVA).

Using the ANOVA output for strain differences, the phenotypic variation attributable to the different strains (σ2str) was calculated based on the following equations, where MS is the mean square value, the subscript r denotes the residual value, and n is the number of specimens per strain:

σ2str=(MSstrMSr)n
σ2r=MSr
H2=σ2str(σ2str+σ2r)

Based on the understanding that all individuals of a given strain are genetically identical, strain variances are genetic variances. All genetic factors contributing to genetic variance are passed from generation to generation, including the dominance and epistatic relationships in inbred strains. The heritability calculated is thus the broad-sense heritability (Falconer and Mackay, 1997).

Genetic correlations were calculated separately for all phenotypes of the femur, radius, and tibia; between the same phenotypes measured on each bone; and between the obesity-related phenotypes and the bone phenotypes. The data used for fat mass and leptin levels were obtained from Cheverud et al. (2004b); only the data from the specimens included in bone analysis were used in determining correlations.

All correlations were directly computed by the GLM as matrices of residual correlations. The genetic correlations were calculated from the strain mean phenotypic values using the model (Sokal and Rohlf, 1995):

Yij=μ+sexi+eij

This takes into account the mean phenotype of the jth strain and the variance due to the ith sex and the residual (eij). Environmental correlations were calculated from the individuals’ phenotypes based on the residuals from the ANOVA model described above with sex, strain, and their interaction as factors (Sokal and Rohlf, 1995). The phenotypic correlations were based on individual data using the model:

Yij=μ+sexi+eij

such that the residual correlations represent the relationship between phenotypes after removing differences due to sex (Sokal and Rohlf, 1995). The significance of the correlations was computed using a t-distribution and correlations whose P-values were 0.05 or less were considered significant.

Genetic markers have been scored for 506 microsatellite loci in the LGXSM RI strains (Hrbek et al., 2006). Markers found to be associated with fat mass and leptin levels (Table 1) (Cheverud et al, 2004a) were tested for their potential association with femoral, radial, and tibial morphological properties and femoral and radial mechanical and material properties. In order to test these hypothesized associations more efficiently, we first performed a data reduction analysis by separately obtaining the principal components of the femoral, radial, and tibial traits. Principal component scores were obtained for each strain for each principal component accounting for more than 10% of the total variance in femoral (3 components), radial (2 components), and tibial (2 components) traits. Thus, these principal components are based on the genetic correlations between traits. A two-way mixed model ANOVA was run using the model:

Yijkl=μ+sexi+genotypej+(sexi×genotypej)+straink(sexi×genotypej)+eijkl

where Yijkl is the principal component score of the lth animal described by the overall phenotypic mean (μ), the deviation from the mean due to the ith sex, the jth genotype, and the kth strain; the interaction between sex and genotype, the nested effect of strain within the sex-by-genotype interaction, and the residual (e) (Sokal and Rohlf, 1995). Multivariate tests were performed using a comparable MANOVA model.

Table 1.

Markers associated with effects on fat mass (F) and leptin (L) levels as well as their confidence intervals, physical positions, and LOD scores [22]

Obesity QTL Traits Affected Begin (Mb) End (Mb) Begin (cM) End (cM) LOD
D1Mit421 F, L 91.11 127.30 56.6 65.0 3.68
D8Mit89 F, L 63.82 116.32 32.0 59.0 3.21
D10Mit47N F 100.41 126.04 59.0 70.0 3.58
D11Mit349 F 34.00 80.56 17.0 46.2 2.34
D18Mit80 F, L 76.19 84.97 47.0 55.0 2.91
DXMit121 F, L 142.68 142.68 69.0 69.0 3.50

Statistical significance was determined using F-ratios, the ratio of MSgenotype divided by MSstrain (sex x genotype); a significant effect suggests that a QTL affecting bone biomechanical properties is located near the marker. An F-ratio of the MSsex x genotype over the MSstrain (sex x genotype) term was used to determine if the sex-by-genotype interaction is significant at a marker. Significant interactions represent a QTL with different effects on males and females (Sokal and Rohlf, 1995). Multivariate tests of QTL effects on bone phenotypes were considered significant at the nominal 5% level. They were not corrected for multiple comparisons because the locations examined were chosen a priori due to an earlier finding of an effect on obesity and/or serum leptin level. Since these locations were chosen based on earlier analyses, they are considered protected from multiple comparisons problems when applied to bone traits. However, QTL effects on fat mass and serum leptin level were, themselves, adjusted for multiple comparisons (Cheverud et al, 2004a).

3. Results

(i) Effects of sex

ANOVA results for phenotypes pooled across the strains show sexual dimorphism at P < 0.05 (Tables 2-3); phenotypic means, standard deviations, and sample sizes for all femoral, radial, and tibial phenotypes are presented in Online Appendix 1. Overall, for the femur, males showed greater phenotypic values for bone area (P = 6.9 × 10-4), inertia (Ixx) (P = 2.5 × 10-6), inertia (Iyy) (P = 2.0 × 10-9), yield moment (P = 2.5 × 10-3), and ultimate moment (P = 2.0 × 10-3), while females were greater for post-yield displacement (P = 3.9 × 10-2) and modulus of elasticity (P = 9.8 × 10-6). Regarding the radius, bone area (P = 3.3 × 10-2), inertia (Ixx) (P = 4.6 × 10-2), and inertia (Iyy) (P = 8.2 × 10-4) were greater in males than in females. For the tibia, bone volume (P = 2.2 × 10-3) and connectivity density (P = 1.1 × 10-2) were larger in females; while male trabeculae had a higher SMI (i.e., more rod-like and less plate-like) than those of females (P = 6.1 × 10-4).

Table 2.

Femoral (F) and radial (R) P-values for the effects of sex and sex-by-strain interaction

Trait* Sex (F) Sex (R) Sex-by-strain (F) Sex-by-strain (R)
Area <0.001 0.033 0.061 0.779
Ixx <0.001 0.046 0.104 0.963
Iyy <0.001 <0.001 0.088 0.718
Rig 0.168 0.149 0.610 0.558
My 0.002 0.125 0.277 0.976
Mu 0.002 0.126 0.532 0.922
d’ fx 0.400 0.278 0.017 0.513
d’ py 0.039 0.261 0.048 0.520
E <0.001 0.820 0.015 0.853
σ ult 0.440 0.585 0.384 0.744
*

Area = cortical bone area; IXX = horizontal moment of inertia; IYY = vertical moment of inertia; Rig = Rigidity; My = yield moment; Mu = ultimate moment; d’ fx = fracture displacement; d’ py = post-yield displacement; E = modulus of elasticity; ultimate tensile strength = σult

Table 3.

Tibial P-values for the effects of sex and sex-by-strain interaction

Trait* Sex Sex-by-Strain
BV/TV 0.002 0.002
ConnD 0.011 0.048
SMI <0.001 0.052
TbN 0.728 0.150
TbTh 0.525 0.103
TbSp 0.817 0.013
*

BV/TV = trabecular bone volume per total volume; ConnD = connectivity density; SMI = structure model index; TbN = trabecular number; TbTh = trabecular thickness; TbSp = trabecular separation.

The sex-by-strain interaction term measures genetic variation in sexual dimorphism between strains and was significant for properties of the femur and tibia (Tables 2-3), including femoral fracture displacement (P = 1.7 × 10-2), post-yield displacement (P = 4.8 × 10-2), and modulus of elasticity (P = 1.5 × 10-2). Significant genetic variation in sexual dimorphism for tibial trabecular bone volume (P = 2.0 × 10-3), connectivity density (P = 4.8 × 10-2), and trabecular separation (P = 1.3 × 10-2) was also discovered. For these traits, the level of sexual dimorphism was different in different strains, indicating that some genes are likely to have sex-specific effects on these traits.

(ii) Heritabilities

The effects of strain (Table 4), when pooled across the sexes, were significant for all femoral, radial, and tibial traits except radial fracture displacement and post-yield displacement which were not different between strains. There were significant strain effects for femoral bone area (P = 1.8 × 10-12), inertia (Ixx) (P < 1.0 × 10-17), inertia (Iyy) (P = 8.3 × 10-13), rigidity (P = 5.0 × 10-8), yield moment (P = 6.8 × 10-7), ultimate moment (P = 3.1 × 10-8), fracture displacement (P = 2.0 × 10-8), post-yield displacement (P = 2.2 × 10-8), modulus of elasticity (P = 4.4 × 10-10), and tensile strength (P = 1.7 × 10-8). Strain effects were noted for radial bone area (P = 1.9 × 10-3), inertia (Ixx) (P = 4.8 × 10-3), inertia (Iyy) (P = 5.7 × 10-4), rigidity (P = 1.4 × 10-4), yield moment (P = 1.0 × 10-4), ultimate moment (P = 1.6 × 10-4), modulus of elasticity (P = 2.6 × 10-4), and tensile strength (P = 8.6 × 10-4). Tibial bone volume (P = 3.7 × 10-10), connectivity density (P = 1.7 × 10-8), structure model index (P = 4.7 × 10-6), trabecular number (P = 2.5 × 10-8), trabecular thickness (P = 1.5 × 10-4), and trabecular separation (P = 4.4 × 10-7) were also affected by strain.

Table 4.

Femoral (F), radial (R), and tibial (T) P-values for the effects of strain, as well as strain variances (σ2str), residual variances (σ2r), and heritabilities (H2)

Trait P σ 2str σ 2r H2
Area (F) <0.001 0.009 0.006 62.2%
Ixx (F) <0.001 <0.001 <0.001 73.5%
Iyy (F) <0.001 0.003 0.002 63.0%
Rig (F) <0.001 33499.967 37201.200 47.4%
My (F) <0.001 31.578 42.652 42.5%
Mu (F) <0.001 36.235 38.944 48.2%
d’ fx (F) <0.001 <0.001 <0.001 49.0%
d’ py (F) <0.001 <0.001 <0.001 48.8%
E (F) <0.001 1836941.667 1501650.000 55.0%
σult (F) <0.001 362.512 373.129 49.3%
Area (R) 0.002 <0.001 <0.001 24.2%
Ixx (R) 0.005 <0.001 <0.001 21.3%
Iyy (R) <0.001 <0.001 <0.001 27.9%
Rig (R) <0.001 755.678 1609.270 32.0%
My (R) <0.001 0.841 1.728 32.7%
Mu (R) <0.001 0.903 1.959 31.5%
d’ fx (R) 0.054 <0.001 0.007 12.2%
d’ py (R) 0.062 <0.001 0.006 11.5%
E (R) <0.001 7410183.333 17053200.000 30.3%
σult (R) <0.001 653.237 1781.990 26.8%
BV/TV (T) <0.001 0.003 0.002 56.0%
ConnD (T) <0.001 404.518 406.081 49.9%
SMI (T) <0.001 0.106 0.166 39.0%
TbN (T) <0.001 0.095 0.098 49.2%
TbTh (T) <0.001 <0.001 <0.001 30.8%
TbSp (T) <0.001 <0.001 <0.001 43.9%

Heritabilities varied widely (Table 4). For the femur, inertia (Ixx) showed the greatest heritability at 73.5% and yield moment had the lowest heritability at 42.5%; all other femoral heritabilities were between 47.0% and 63.0%. The greatest radial heritability was only 32.7% for yield moment, the lowest significant heritability was 21.3% for inertia (Ixx), and other significant radial heritabilities lay within this range. Bone volume showed the greatest heritability in the tibia at 56.0%, trabecular thickness was the least heritable at 30.8%, and all other tibial phenotypes had heritabilities between 39.0% and 50.0%.

(iii) Genetic correlations

Genetic correlations are provided between femoral phenotypes, between radial phenotypes, and between tibial phenotypes (Online Appendix 2). They are also provided between these bone phenotypes and obesity-related traits (Table 5) and across the femoral, radial, and tibial phenotypes (Online Appendix 2). All correlations stronger than rG = ±0.35 (rG2 = 0.12) were significant at the P = 0.05 level.

Table 5.

Bone-obesity genetic correlations, with significant correlations in bold-face. Femoral (F), radial (R), tibial (T)

Trait TotFat Leptin
Area (F) 0.45 0.16
Ixx (F) 0.19 -0.13
Iyy (F) 0.30 -0.01
Rig (F) 0.64 0.42
My (F) 0.58 0.35
Mu (F) 0.59 0.31
d’ fx (F) -0.19 -0.12
d’ py (F) -0.16 -0.11
E (F) 0.33 0.45
σult (F) 0.37 0.48
Area (R) 0.44 0.07
Ixx (R) 0.56 0.33
Iyy (R) 0.45 0.11
Rig (R) 0.46 0.25
My (R) 0.47 0.28
Mu (R) 0.45 0.23
d’ fx (R) 0.20 0.26
d’ py (R) 0.20 0.26
E (R) 0.06 0.12
σult (R) 0.05 0.11
BV/TV (T) 0.35 0.20
ConnD (T) 0.13 0.06
SMI (T) -0.55 -0.29
TbN (T) 0.03 0.01
TbTh (T) 0.40 0.19
TbSp (T) -0.12 -0.08

There were many significant intra-bone and inter-bone genetic correlations. Within a bone, no bone property varied independently of all others, although femoral fracture displacement, modulus of elasticity, and tensile strength; radial fracture displacement and post-yield displacement; and tibial trabecular thickness were not correlated with most other traits measured on the same bone. Across the bones, femoral tensile strength varied independently of all radial and tibial phenotypes; femoral fracture displacement, post-yield displacement, and modulus of elasticity varied independently of all tibial traits; radial tensile strength varied independently of all femoral phenotypes; radial fracture displacement and post-yield displacement varied independently of all tibial traits; and tibial trabecular number varied independently of all radial traits. There were also many phenotypes that, when compared across bones, showed independence from most phenotypes of other bones.

Bone phenotypes were also correlated with fat mass and leptin levels. Fat mass was positively correlated with femoral bone area, rigidity, yield moment, ultimate moment, and tensile strength (rG2 = 0.14-0.41); positively correlated with radial bone area, inertia (Ixx and Iyy), rigidity, yield moment, and ultimate moment (rG2 = 0.19-0.31); and positively correlated with tibial bone volume and trabecular thickness and negatively correlated with SMI (rG2 = 0.12-0.31). Leptin levels were positively correlated with femoral rigidity, yield moment, modulus of elasticity, and tensile strength (rG2 = 0.12-0.23). Leptin did not correlate with any radial or tibial traits.

(iv) Principal components

Three femoral, two radial, and two tibial principal components were obtained jointly accounting for 92%, 83%, and 91% of the total variance between strains in these trait sets, respectively (Table 6). The first femoral principal component (52% of variance) primarily contrasts size (area, Ixx, Iyy) and structural stiffness and strength (My, Mu) with measures of ductility (d’fx, d’fy). Elastic modulus and ultimate tensile strength have relatively small, negative loadings. The second femoral component (26%) is positively related to rigidity, elastic modulus, and ultimate tensile strength (σult) in contrast to negative coefficients for the moments of inertia (Ixx, Iyy), while the third component (14%) is essentially a measure of ductility (d’fx, d’fy).

Table 6.

Femoral, Radial, and Tibial Principal Components

Trait Femur1 Femur2 Femur3 Radius1 Radius2 Trait Tibia1 Tibia2
Area 0.932 0.056 0.283 0.735 0.576 BV/TV 0.965 0.203
I(XX) 0.863 -0.418 0.147 0.621 0.689 ConnD 0.929 -0.239
I(YY) 0.903 -0.326 0.175 0.756 0.418 SMI -0.841 -0.403
Rig 0.498 0.701 0.287 0.957 -0.01 TbN 0.849 -0.432
M(y) 0.904 0.281 0.037 0.922 0.182 TbTh 0.491 0.819
M(u) 0.892 0.322 0.258 0.967 0.102 TbSp -0.884 0.394
d’fx -0.602 -0.212 0.75 -0.437 0.742
d’py -0.644 -0.085 0.758 -0.434 0.735
E -0.391 0.873 0.043 0.588 -0.711
σ(ult) -0.143 0.902 -0.007 0.538 -0.675

% Total
Variance 52 26 14 52 31 71 21

The first radial principal component (52%) is similar to the first femoral component (vector correlation between Femur1 and Radius1 = 0.82), contrasting size (area, Ixx, Iyy,), structural stiffness and strength (rigidity, My, Mu) with ductility (d’fx, d’fy) but with elastic modulus and ultimate tensile strength (σult) having positive coefficients instead of negative ones. The second radial component (31%) contrasts size (area, Ixx, Iyy) and ductility (d’fx, d’fy) with elastic modulus and ultimate tensile strength (σult).

The first tibial principal component (71%) contrasts measures related to bone volume and trabecular number, thickness, and connectivity (BV/TV, ConnD, TbN, TbTh) with trabecular separation (TbSp) and structure model index (SMI). The second component (21%) contrasts trabecular thickness and separation (TbTh, TbSp) with trabecular number and structure model index (TbN, SMI).

(v) Quantitative trait loci

Fat mass and leptin QTLs have significant effects on bone morphology and material properties (see Table 7). A MANOVA using all seven principal components as dependent variables and all six QTL genotypes as independent variables indicates only an overall 0.008 probability of obtaining the observed effects under the null hypothesis of no influence of fat mass/leptin loci on bone properties. The genotypes jointly have significant effects on Femur1 (P = 0.027), Radius1 (P = 0.037), and Radius2 (P = 0.016). Four of the six obesity/leptin QTLs had multivariate significant effects on overall bone properties and all six had significant effects on at least one bone property principal component (see Table 7).

Table 7.

Probabilities of obesity QTLs having no effects on bone property principal components. The “Overall” column is a multivariate test for each locus separately while the “Overall” row is the probability for each bone property principal component. The intersection of the “overall” row and column provides the overall probability of no effect of obesity QTLs on bone property principal components. ‘ns’ indicates not significant at the 0.10 level

Principal Components

Obesity QTL Overall Femur1 Femur2 Femur3 Radius1 Radius2 Tibia1 Tibia2
D1Mit421 0.078 ns ns ns ns 0.035 ns ns
D8Mit89 0.020 0.012 ns 0.082 0.049 0.049 ns ns
D10Mit47N 0.247 0.027 ns ns ns ns ns ns
D11Mit349 0.005 0.018 ns 0.056 0.018 0.039 ns ns
D18Mit80 0.002 ns ns ns 0.104 0.003 ns ns
DXMit121 0.041 0.004 ns ns 0.005 ns ns 0.105

Overall 0.008 0.027 0.405 0.488 0.037 0.016 0.157 0.293

4. Discussion

(i) Heritabilities and genetic correlations

The data obtained from the LGXSM RI mouse strains for osteoporosis-related traits in this study showed that a substantial proportion of the phenotypic variance in these traits is due to heritable genetic causes. The greatest heritabilities were found for femoral and tibial morphological properties and, with the exception of three radial phenotypes, all bone phenotypes investigated showed a significant proportion of heritable genetic variation. Clearly, this strain set displays substantial genetic variation for bone morphological, mechanical, and material characteristics.

The correlations with serum leptin levels present further insight into the relationship between leptin and various osseous characteristics. Femoral results agreed with the conclusions from Hamrick et al. (2004, 2005), supporting the link between the increased levels of this hormone and stronger femora. In contrast, no radial or tibial phenotypes were significantly correlated with leptin. The absence of genetic correlations with leptin indicates a lack of genetic relationship between serum leptin levels and radial or tibial trabecular properties, at least in our mouse population. In contrast to our lack of association between leptin levels and tibial trabecular mass, other murine studies have discovered such relationships involving vertebral bodies and the femur. Even so, the effects of leptin may differ for different osseous elements and for different bone compartments (cortical and trabecular) (Hamrick et al., 2004), and may indeed be specific to the leptin-deficient mutant mice utilized in this earlier research. Li et al. (2008) find no relationship between leptin levels and bone mass across mouse strains and that the fat-bone mass relationship may differ depending on diet and genotype.

The adiposity data show that there are strong genetic relationships between fat mass and bone density, ductility, size, and strength. Fat mass was correlated to more bone phenotypes in all three bones than was leptin. Some human quantitative genetic studies have found that the bone-obesity relationship is not genetic but largely environmental (Nguyen et al. 1998) and that genetic correlations and pleiotropic quantitative trait loci between bone and obesity (Tang et al., 2007), are mediated through general body weight factors or muscle mass which, when controlled for, eliminate the positive association between bone mass and obesity (Zhou et al., 2007). This is not the case in our set of LGXSM RI lines. The genetic correlation between fat mass and body weight at necropsy is 0.91 while their environmental correlation is 0.85 (Cheverud et al, 2004b). These high correlations may be due, in part, to the fact that all animals were reared on a high fat diet. Fat mass, as measured here, on average makes up about 20% of the total body weight. Given the part-whole relationship of body weight and fat mass and the very high genetic and environmental correlations between these two traits in our population, statistical separation of the effects of lean and fat mass on bone properties is not informative. We have no independent data on muscle mass in these mice. Given the observed correlations between fat mass and bone properties, and assuming our findings extend to other mammals, it is evident that genes which contribute to more physically obese individuals are inherited with those that help reduce the likelihood of fracture in the femur, radius, and tibia.

(ii) Principal components

Principal components were calculated to describe the overall pattern of variations in bone morphology, mechanical, and material properties in the LG/J by SM/J intercross. Measures of cross-sectional morphology and bone biomechanical properties were taken on the femur and radius. The first component for both femoral and radial traits were quite similar (r = 0.82) and contrasted measures of size and structural stiffness and strength with measures of ductility. This contrast can be interpreted as representing the differences between large, stiff, strong, and more brittle bones (femora or radii) versus smaller, less stiff, weaker, and more ductile bones. This grouping of traits is generally consistent with the paradigm described by Jepsen et al. (2003), whereby bone size was positively associated with stiffness and failure load across eight inbred mouse strains.

The second femoral and radial principal components were similar in that they both contrasted estimated material properties (elastic modulus, ultimate tensile strength) with moments of inertia. This grouping is consistent with the beam theory equations used to compute the material properties (see Methods), as moment of inertia (Ixx) is the denominator in the elastic modulus and ultimate tensile moment equations. Recalling that principal components are statistically independent of each other, the contrast of moments of inertia with material properties should be considered among femora (or radii) with equal scores on the first principal component. In other words, this contrast is between femora of the same stiffness, strength, and ductility that have relatively high material properties with small moments of inertia versus those that have relatively low material properties and large moments of inertia.

The third femoral principal component is a scale that runs from brittle to ductile. The fact that measures of ductility (d’fx, d’fy) weight most strongly in this component without strong weightings from other traits suggests that ductility is largely independent of morphology and whole-bone stiffness and strength. This is consistent with the findings of Jepsen et al. (2003). Also related to ductility, the first two femoral and radial principal components each contrast measures of ductility against measures of material properties. It is possible that bone composition, specifically ash content (which we did not measure), would explain this contrast. Bone tissue that is more highly mineralized will have greater material stiffness and strength, but less ductility (Jepsen et al., 2003; Currey, 1984).

Measurements were also taken on the trabecular bone in the proximal tibia. The first tibial principal component, which captures 71% of the total variance, is a contrast between measures that increase with trabecular bone density (BV/TV, ConnD, TbTh, TbN) and measures that decrease with increased trabecular bone density (TbSp, SMI). Tibia that have high scores on this first component have many, closely-spaced, thick, interconnected, plate-like trabeculae leading to high trabecular bone volume while those with low scores have relatively few, sparsely distributed, thin, unconnected, rod-like trabeculae leading to low trabecular bone volume.

(iii) Quantitative trait loci

Analysis of the effects of obesity and leptin quantitative trait loci on bone properties indicates that obesity loci also have effects on bone morphology, biomechanical, and material properties and are consistent with the observed genetic correlations between obesity and bone traits. While for any one specific obesity locus we cannot eliminate the possibility that the osseous effects are due to separate, closely-linked locus, it seems highly unlikely that this would be true for all six obesity/leptin loci examined. Four of the six loci affected the first femoral and radial principal components and the second radial principal component. Overall, the most prominent effects of obesity QTLs were on these three components. Thus, obesity QTLs at D8Mit89, D10Mit47N, D11Mit349, and DXMit121 affect the difference between large, stiff, strong, brittle bones and smaller, less stiff, weaker, more ductile ones. Obesity QTLs (D8Mit89, D11Mit349, D18Mit18, DXMit121) also affect the second radial principal component. Two of the obesity QTLs that affected the second radial principal component (D8Mit89, D11Mit349) also had marginally significant affects on the related third femoral component. No obesity QTLs affected the second femoral or first tibial principal components and only a marginally significant effect was detected at a single obesity QTL (DXMit121) for the second tibial component.

These results confirm the known human epidemiological relationships between obesity and osteoporosis in our mouse model population. Genetic correlations demonstrate that genes influencing phenotypes related to obesity and osteoporosis are inherited together and QTL analysis reveals potential genomic loci associated with these phenotypic relationships. However, it must be noted that we can only crudely map bone QTLs in this population of mice. It is possible that separate but linked genetic factors may be responsible for the apparent bone-obesity pleiotropic effects reported here. Further studies in populations with enhanced levels of recombination will be necessary to separate the possibilities of genetic correlation due to close linkage from those due to pleiotropy.

Furthermore, obesity QTLs that affect bone properties allow for identification of candidate genes at each locus responsible for the relationships observed; candidate genes can be found at www.ensemble.org (Hubbard et al., 2005). Examples include Npy1r and Npy5r, genes that encode neuropeptide Y (NPY) receptors Y1 (NPY1-R) and Y5 (NPY5-R) on chromosome 8 (Hubbard et al., 2005). These two positional candidates are found in the genomic region associated with obesity, femoral principal components 1 and 3 and radial components 1 and 2. NPY affects hypothalamic control of food and energy consumption. Interestingly, NPY and leptin may regulate energy intake and expenditure in a homeostatic loop in which NPY production is reduced by leptin and NPY stimulates leptin production (Wang et al., 1997). In mice, NPY leads to increased body weight and body fat when it binds to either NPY1-R or NPY5-R (Henry et al., 2005); these effects could also influence bone morphology and mechanics (Baldock et al., 2007; Castro et al., 2005; Reid et al., 1992; Stewart et al., 2002). Moreover, mice lacking the NPY1-R receptor have elevated bone and adipose tissue mass (Baldock et al., 2007).

Another interesting example of genes that may influence the obesity-osteoporosis relationship is Igfbp2 and Igfbp5 on chromosome 1. These tightly-linked genes are approximately 20 Mb from an obesity QTL that also affects the second radial principal component. Igfbp2 and Igfbp5 encode insulin-like growth factor binding proteins (IGFB2, IGFB5) that affect bone formation. Whereas IGFBP2 inhibits bone formation (Fisher et al., 2005), IGFBP5 stimulates it (Richman et al., 1999). When compared to control subjects, a study showed osteoporotic individuals to have increased levels of IGFBP2 and decreased levels of IGFBP5 (Jehle et al., 2003); another study found both IGFBP2 and IGFBP5 in decreased levels in type-II diabetes mellitus patients, but only IGFBP2 in decreased levels in obese diabetic patients (Mohan et al., 1995). Further investigation of this locus may be important in elucidating the genetic relationship between obesity and osteoporosis.

(iv) Conclusions

We have shown that there is substantial genetic variation in a number of osteoporosis-related phenotypes in LGXSM RI strain panel. More importantly, this study also indicates that genetic effects on obesity and osteoporosis are related to one another and likely map to many of the same quantitative trait loci. Thus, the LG/J by SM/J intercross mice provide a new model for studying normal genetic variation in the complex traits of obesity, osteoporosis, and their interrelationships. Further study of populations derived from this intercross will allow us to more precisely define these relationships and identify the genetic variations responsible for them.

Acknowledgements

We thank Dr. D. Tab Rasmussen; L. Susan Pletscher, Bing Wang, Jane Kenney-Hunt, Michael Brodt and Brian Uthgenannt at Washington University for help in collecting and analyzing the data and in the preparation of this manuscript. This work was supported by NIH grants DK75112, DK55736, and RR015116.

Online Appendix 1: Phenotypic means, standard deviations, and counts

Table A1.

Femoral phenotypic means, standard deviations, and counts

Strain Sex Area
(mm2)
Std Dev
(mm2)
N Ixx
(mm4)
Std Dev
(mm4)
N Iyy
(mm4)
Std Dev
(mm4)
N
4 F 1.025 0.029 3 0.149 0.002 3 0.250 0.056 3
4 M 1.101 0.067 3 0.168 0.019 3 0.312 0.064 3
5 F 1.018 0.056 3 0.146 0.015 3 0.245 0.027 3
5 M 1.150 0.063 3 0.172 0.025 3 0.313 0.025 3
10 F 0.966 0.070 3 0.117 0.020 3 0.192 0.043 3
10 M 1.013 0.075 3 0.151 0.017 3 0.275 0.020 3
15 F 1.089 0.050 3 0.201 0.019 3 0.350 0.047 3
15 M 1.199 0.026 3 0.248 0.031 3 0.455 0.037 3
18 F 0.926 0.020 3 0.121 0.007 3 0.201 0.010 3
18 M 1.082 0.071 3 0.152 0.013 3 0.291 0.028 3
19 F 1.040 0.037 3 0.141 0.006 3 0.255 0.021 3
19 M 1.235 0.062 3 0.194 0.015 3 0.413 0.023 3
20 F 1.105 0.039 3 0.137 0.008 3 0.269 0.016 3
20 M 1.114 0.028 3 0.133 0.013 3 0.294 0.027 3
22 F 0.878 0.113 3 0.089 0.023 3 0.166 0.040 3
22 M 0.966 0.040 3 0.117 0.009 3 0.237 0.016 3
23 F 0.975 0.184 3 0.137 0.040 3 0.246 0.041 3
23 M 1.094 0.103 3 0.159 0.018 3 0.328 0.071 3
31 F 1.316 0.085 3 0.198 0.029 3 0.368 0.053 3
31 M 1.320 0.105 3 0.211 0.017 3 0.412 0.030 3
33 F 0.927 0.033 3 0.126 0.013 3 0.228 0.044 3
33 M 0.996 0.093 3 0.141 0.023 3 0.292 0.045 3
35 F 1.080 0.116 3 0.129 0.020 3 0.258 0.073 3
35 M 1.018 0.040 3 0.156 0.026 3 0.253 0.022 3
38 F 0.982 0.046 4 0.162 0.012 4 0.254 0.028 4
38 M 0.920 0.022 3 0.159 0.014 3 0.262 0.016 3
45 F 0.939 0.049 3 0.106 0.012 3 0.187 0.024 3
45 M 0.961 0.087 3 0.119 0.017 3 0.231 0.053 3
46 F 1.067 0.021 3 0.141 0.006 3 0.273 0.031 3
46 M 0.990 0.144 3 0.122 0.020 3 0.260 0.098 3
48 F 0.951 0.036 3 0.118 0.013 3 0.201 0.014 3
48 M 0.989 0.063 3 0.123 0.008 3 0.256 0.036 3
Femoral phenotypic data.
Strain Sex N Rig
(N*mm2)
Std Dev
(N*mm2)
N My
(N*mm)
Std Dev
(N*mm)
N
4 F 3 952.506 111.235 3 37.901 9.861 3
4 M 3 961.786 78.276 3 42.674 7.456 3
5 F 3 972.538 192.240 3 30.850 2.958 3
5 M 3 1039.400 64.104 3 48.575 8.589 3
10 F 3 1017.263 98.258 3 39.444 4.188 3
10 M 3 1027.714 207.509 3 33.843 8.494 3
15 F 3 979.346 235.418 3 41.545 10.095 3
15 M 3 766.761 147.463 3 44.359 7.812 3
18 F 3 974.317 191.545 3 31.295 2.321 3
18 M 3 1036.749 213.438 3 41.006 11.393 3
19 F 3 1058.220 297.214 3 40.309 2.925 3
19 M 3 920.788 219.845 3 48.209 4.606 3
20 F 3 903.389 102.373 3 41.639 2.766 3
20 M 3 1036.055 6.665 3 45.027 8.273 3
22 F 3 1007.204 213.409 3 31.937 2.611 3
22 M 3 746.488 40.780 3 39.492 1.111 3
23 F 3 787.387 412.537 3 37.792 8.899 3
23 M 3 994.895 151.083 3 49.493 3.692 3
31 F 3 1824.344 243.291 3 59.752 8.562 3
31 M 3 1519.553 282.053 3 54.817 4.954 3
33 F 3 912.506 112.141 3 32.701 3.211 3
33 M 3 734.346 26.892 3 35.716 6.414 3
35 F 3 1098.665 302.025 3 35.330 7.352 3
35 M 3 1154.794 185.239 3 38.891 6.149 3
38 F 4 880.795 215.134 4 30.973 4.037 4
38 M 3 789.888 64.996 3 33.504 10.154 3
45 F 3 1130.077 223.653 3 34.378 5.493 3
45 M 3 1026.468 279.628 3 38.921 0.169 3
46 F 3 957.940 148.929 3 41.704 2.892 3
46 M 3 813.515 89.678 3 41.907 8.450 3
48 F 3 1001.095 60.356 2 31.815 3.890 2
48 M 3 1007.337 140.897 3 30.453 6.979 3
Femoral phenotypic data.
Strain Sex Mu
(N*mm)
Std Dev
(N*mm)
N d’ fx
(mm/mm2)
Std Dev
(mm/mm2)
N d’ py
(mm/mm2)
Std Dev
(mm/mm2)
N
4 F 44.897 4.520 3 0.068 0.009 3 0.031 0.021 3
4 M 52.393 3.772 3 0.081 0.009 3 0.038 0.018 3
5 F 40.616 1.034 3 0.162 0.042 3 0.130 0.045 3
5 M 56.025 9.472 3 0.088 0.022 3 0.045 0.018 3
10 F 45.150 3.758 3 0.056 0.002 3 0.022 0.002 3
10 M 45.541 5.241 3 0.072 0.021 3 0.041 0.029 3
15 F 45.652 6.780 3 0.055 0.007 3 0.016 0.015 3
15 M 51.664 4.668 3 0.078 0.016 3 0.024 0.019 3
18 F 41.898 4.414 3 0.078 0.014 3 0.047 0.011 3
18 M 50.044 6.200 3 0.077 0.013 3 0.037 0.025 3
19 F 45.060 2.875 3 0.085 0.033 3 0.048 0.034 3
19 M 52.762 1.237 3 0.074 0.005 3 0.022 0.010 3
20 F 48.576 0.363 3 0.113 0.019 3 0.068 0.015 3
20 M 51.231 7.171 3 0.085 0.015 3 0.045 0.014 3
22 F 37.533 5.780 3 0.083 0.011 3 0.049 0.016 3
22 M 42.453 0.517 3 0.089 0.004 3 0.035 0.006 3
23 F 44.068 14.285 3 0.097 0.018 3 0.048 0.019 3
23 M 54.805 7.612 3 0.084 0.012 3 0.039 0.012 3
31 F 69.570 10.073 3 0.058 0.006 3 0.027 0.007 3
31 M 69.296 11.892 3 0.056 0.011 3 0.022 0.015 3
33 F 42.347 3.138 3 0.081 0.014 3 0.050 0.011 3
33 M 44.163 3.845 3 0.127 0.044 3 0.084 0.047 3
35 F 44.031 6.050 3 0.082 0.011 3 0.052 0.013 3
35 M 48.244 3.330 3 0.077 0.021 3 0.046 0.014 3
38 F 42.288 2.671 4 0.092 0.038 4 0.059 0.042 4
38 M 41.259 7.893 3 0.093 0.031 3 0.055 0.034 3
45 F 43.456 6.392 3 0.100 0.040 3 0.069 0.037 3
45 M 45.066 6.197 3 0.088 0.007 3 0.050 0.013 3
46 F 47.610 5.984 3 0.072 0.004 3 0.033 0.010 3
46 M 44.654 5.977 3 0.075 0.010 3 0.026 0.005 3
48 F 44.129 6.170 2 0.162 0.004 2 0.132 0.004 2
48 M 43.144 6.196 3 0.141 0.033 3 0.112 0.031 3
Femoral phenotypic data.
Strain Sex E
(N/mm2)
Std Dev
(N/mm2)
N σult
(N/mm2)
Std Dev
(N/mm2)
N
4 F 6396.653 669.077 3 194.851 17.253 3
4 M 5778.656 865.692 3 202.672 13.436 3
5 F 6630.925 606.475 3 180.796 8.331 3
5 M 6129.233 1039.177 3 210.455 14.809 3
10 F 8761.751 667.187 3 237.328 10.424 3
10 M 6850.531 1346.795 3 193.082 22.988 3
15 F 4876.340 1099.847 3 164.164 35.452 3
15 M 3165.155 935.453 3 161.758 20.597 3
18 F 8063.404 1460.403 3 211.977 20.024 3
18 M 6929.315 1887.967 3 208.252 25.455 3
19 F 7538.199 2259.036 3 200.022 14.057 3
19 M 4810.338 1401.353 3 183.726 13.762 3
20 F 6656.449 1178.833 3 217.238 6.612 3
20 M 7821.650 789.361 3 224.878 20.097 3
22 F 11416.997 1247.978 3 235.839 18.555 3
22 M 6387.693 581.233 3 222.617 13.923 3
23 F 5515.033 1892.290 3 212.459 30.171 3
23 M 6267.126 546.420 3 235.634 20.018 3
31 F 9243.673 647.625 3 231.841 9.547 3
31 M 7176.396 724.746 3 227.467 20.907 3
33 F 7253.646 807.923 3 206.787 12.599 3
33 M 5280.853 770.814 3 202.488 8.243 3
35 F 8463.431 1527.122 3 210.186 33.986 3
35 M 7635.594 2110.468 3 205.879 12.361 3
38 F 5406.981 988.147 4 174.287 10.345 4
38 M 5003.465 728.963 3 170.013 28.976 3
45 F 10575.288 987.393 3 240.985 14.260 3
45 M 8494.620 1272.376 3 233.592 16.000 3
46 F 6814.484 1102.929 3 216.351 30.096 3
46 M 6883.648 1907.492 3 215.567 12.018 3
48 F 8516.651 820.258 2 221.045 6.278 2
48 M 8221.120 1324.223 3 208.888 23.027 3

Table A2.

Radial phenotypic means, standard deviations, and counts

Strain Sex Area
(mm2)
Std Dev
(mm2)
N Ixx
(mm4)
Std Dev
(mm4)
N Iyy
(mm4)
Std Dev
(mm4)
N
4 F 0.294 0.027 3 0.009 0.001 3 0.012 0.004 3
4 M 0.309 0.006 3 0.010 0.001 3 0.012 0.001 3
5 F 0.266 0.016 3 0.008 0.002 3 0.007 0.000 3
5 M 0.306 0.011 2 0.010 0.002 2 0.011 0.001 2
10 F 0.280 0.016 3 0.007 0.001 3 0.010 0.002 3
10 M 0.289 0.027 3 0.008 0.001 3 0.012 0.002 3
15 F 0.307 0.008 3 0.011 0.001 3 0.010 0.000 3
15 M 0.310 0.008 2 0.011 0.000 2 0.012 0.001 2
18 F 0.292 0.015 2 0.008 0.001 2 0.011 0.000 2
18 M 0.297 0.018 3 0.009 0.002 3 0.011 0.000 3
19 F 0.295 0.002 2 0.008 0.000 2 0.010 0.002 2
19 M 0.326 0.009 2 0.010 0.001 2 0.014 0.000 2
20 F 0.273 0.012 3 0.006 0.001 3 0.009 0.000 3
20 M 0.304 0.021 3 0.008 0.001 3 0.013 0.003 3
22 F 0.267 0.036 3 0.008 0.003 3 0.008 0.002 3
22 M 0.287 0.021 3 0.009 0.002 3 0.010 0.002 3
23 F 0.276 0.046 3 0.008 0.002 3 0.009 0.002 3
23 M 0.296 0.004 3 0.009 0.001 3 0.010 0.001 3
31 F 0.347 0.027 3 0.012 0.004 3 0.015 0.002 3
31 M 0.339 0.021 2 0.012 0.001 2 0.015 0.001 2
33 F 0.282 0.037 3 0.008 0.002 3 0.009 0.003 3
33 M 0.285 0.018 2 0.008 0.002 2 0.010 0.003 2
35 F 0.311 0.025 3 0.009 0.002 3 0.010 0.001 3
35 M 0.326 0.004 3 0.012 0.001 3 0.011 0.003 3
38 F 0.285 0.016 4 0.008 0.001 4 0.009 0.002 4
38 M 0.278 0.013 3 0.008 0.001 3 0.009 0.001 3
45 F 0.273 0.011 3 0.007 0.001 3 0.007 0.000 3
45 M 0.300 0.034 3 0.009 0.004 3 0.011 0.002 3
46 F 0.288 0.015 2 0.010 0.003 2 0.009 0.001 2
46 M 0.254 0.077 2 0.008 0.005 2 0.008 0.006 2
48 F 0.285 0.004 3 0.008 0.001 3 0.010 0.001 3
48 M 0.295 0.027 2 0.010 0.002 2 0.011 0.001 2
Radial phenotypic data.
Strain Sex N Rig
(N*mm2)
Std Dev
(N*mm2)
N My
(N*mm)
Std Dev
(N*mm)
N
4 F 3 208.452 66.175 2 7.929 2.070 2
4 M 3 208.442 60.758 3 8.049 2.182 3
5 F 3 188.174 48.823 3 7.900 1.074 3
5 M 2 210.504 0.964 2 9.164 2.034 2
10 F 3 143.579 20.775 3 6.652 0.703 3
10 M 3 165.476 25.315 3 7.026 1.032 3
15 F 3 201.164 13.305 3 7.721 0.220 3
15 M 2 213.282 4.569 2 8.499 0.506 2
18 F 2 195.709 18.179 2 8.504 0.767 2
18 M 3 231.311 51.202 3 8.677 1.151 3
19 F 2 202.102 20.284 2 6.243 1.946 2
19 M 2 228.577 37.915 2 9.844 1.107 2
20 F 3 163.223 28.455 3 6.865 0.653 3
20 M 3 187.822 20.641 3 7.804 1.579 3
22 F 3 164.767 36.905 3 8.128 2.318 3
22 M 3 190.113 28.891 3 7.818 1.363 3
23 F 3 157.418 37.325 3 6.346 1.493 3
23 M 3 183.292 14.348 3 7.506 0.283 3
31 F 3 287.523 55.187 3 10.651 1.461 3
31 M 2 191.731 19.589 2 9.881 0.656 2
33 F 3 163.192 68.933 3 6.730 1.528 3
33 M 2 153.601 49.130 2 6.866 1.452 2
35 F 3 148.768 40.597 3 7.054 0.495 3
35 M 3 201.820 88.032 3 8.132 1.549 3
38 F 4 124.727 12.688 4 6.267 0.835 4
38 M 3 123.007 10.119 3 6.166 0.422 3
45 F 3 98.258 4.875 3 5.173 0.315 3
45 M 3 144.774 50.751 3 6.238 2.776 3
46 F 2 163.083 4.988 2 7.490 1.445 2
46 M 2 153.353 39.986 2 6.643 1.020 2
48 F 3 122.659 6.301 3 6.208 0.199 3
48 M 2 145.520 6.882 2 6.854 0.374 2
Radial phenotypic data
Strain Sex Mu
(N*mm)
Std Dev
(N*mm)
N d’ fx
(mm/mm2)
Std Dev
(mm/mm2)
N d’ py
(mm/mm2)
Std Dev
(mm/mm2)
N
4 F 9.183 2.350 2 0.177 0.013 2 0.143 0.015 2
4 M 9.378 2.054 3 0.096 0.050 3 0.060 0.047 3
5 F 9.137 1.193 3 0.157 0.039 3 0.119 0.037 3
5 M 10.080 1.295 2 0.178 0.066 2 0.136 0.052 2
10 F 7.868 0.655 3 0.110 0.004 3 0.072 0.005 3
10 M 8.270 0.848 3 0.108 0.055 3 0.071 0.047 3
15 F 9.411 0.358 3 0.106 0.053 3 0.072 0.053 3
15 M 9.630 0.616 2 0.132 0.103 2 0.095 0.102 2
18 F 9.364 0.541 2 0.052 0.004 2 0.012 0.004 2
18 M 9.977 1.687 3 0.071 0.033 3 0.037 0.035 3
19 F 9.407 0.251 2 0.119 0.011 2 0.093 0.015 2
19 M 11.156 0.462 2 0.130 0.076 2 0.087 0.089 2
20 F 8.111 0.972 3 0.111 0.023 3 0.075 0.025 3
20 M 8.890 1.418 3 0.163 0.017 3 0.126 0.022 3
22 F 8.968 1.996 3 0.239 0.044 3 0.195 0.049 3
22 M 8.868 1.118 3 0.185 0.128 3 0.148 0.124 3
23 F 6.945 1.792 3 0.099 0.058 3 0.066 0.058 3
23 M 8.708 0.403 3 0.148 0.085 3 0.110 0.087 3
31 F 11.797 1.985 3 0.177 0.056 3 0.142 0.055 3
31 M 10.619 0.295 2 0.227 0.026 2 0.179 0.013 2
33 F 8.201 1.622 3 0.173 0.027 3 0.137 0.032 3
33 M 7.860 2.217 2 0.215 0.023 2 0.173 0.020 2
35 F 7.947 0.697 3 0.149 0.047 3 0.107 0.044 3
35 M 9.626 1.699 3 0.225 0.051 3 0.185 0.048 3
38 F 7.372 0.961 4 0.157 0.052 4 0.114 0.051 4
38 M 7.277 0.515 3 0.227 0.150 3 0.183 0.149 3
45 F 6.110 0.717 3 0.260 0.156 3 0.217 0.149 3
45 M 7.273 3.377 3 0.260 0.204 3 0.226 0.202 3
46 F 8.350 1.126 2 0.208 0.221 2 0.162 0.201 2
46 M 7.346 0.827 2 0.169 0.069 2 0.131 0.065 2
48 F 6.947 0.264 3 0.197 0.037 3 0.151 0.036 3
48 M 7.837 0.934 2 0.378 0.144 2 0.334 0.151 2
Radial phenotypic data
Strain Sex E
(N/mm2)
Std Dev
(N/mm2)
N σult
(N/mm2)
Std Dev
(N/mm2)
N
4 F 23477.020 2356.166 2 322.991 31.820 2
4 M 20815.792 4017.069 3 309.686 49.334 3
5 F 25000.422 9951.498 3 373.757 84.178 3
5 M 22579.685 4615.898 2 339.492 3.950 2
10 F 21815.909 1821.764 3 338.671 26.642 3
10 M 21063.755 2778.666 3 300.579 15.638 3
15 F 18617.970 832.426 3 302.133 4.524 3
15 M 19265.954 725.964 2 298.861 13.643 2
18 F 24112.525 756.934 2 339.260 3.977 2
18 M 25725.096 783.784 3 352.205 20.354 3
19 F 24595.450 3691.831 2 345.690 21.046 2
19 M 23360.634 1798.810 2 358.088 28.109 2
20 F 25563.225 2600.743 3 369.811 17.592 3
20 M 24897.018 2637.201 3 351.666 42.258 3
22 F 21072.440 4492.853 3 348.601 26.293 3
22 M 21042.639 1697.767 3 316.297 6.421 3
23 F 18865.627 2581.908 3 259.322 38.425 3
23 M 21503.165 3866.639 3 320.720 22.090 3
31 F 23844.934 4665.256 3 334.142 10.991 3
31 M 15631.492 592.194 2 296.389 19.782 2
33 F 19074.227 3601.796 3 312.857 25.391 3
33 M 18670.307 2215.058 2 296.603 50.886 2
35 F 16188.725 3381.280 3 282.497 31.534 3
35 M 17861.355 9188.054 3 293.896 70.199 3
38 F 16187.043 2413.158 4 295.522 49.190 4
38 M 15428.441 1702.636 3 283.252 14.412 3
45 F 14061.891 816.024 3 268.773 46.289 3
45 M 15436.356 1202.287 3 235.804 67.067 3
46 F 17751.385 6375.310 2 282.316 10.388 2
46 M 23654.276 10698.415 2 347.969 155.624 2
48 F 14814.430 2824.239 3 259.717 18.967 3
48 M 14291.330 3633.997 2 252.941 2.032 2

Table A3.

Tibial phenotypic means, standard deviations, and counts

Strain Sex BV/TV Std Dev N ConnD
(1/mm3)
Std Dev
(1/mm3)
N SMI Std Dev N
4 F 0.245 0.033 3 48.870 27.751 3 1.908 0.427 3
4 M 0.195 0.071 3 31.442 28.353 3 2.273 0.495 3
5 F 0.302 0.023 3 84.287 30.850 3 2.029 0.168 3
5 M 0.190 0.038 3 31.455 13.034 3 2.373 0.161 3
10 F 0.211 0.024 2 32.922 14.065 2 2.180 0.132 2
10 M 0.162 0.048 3 23.363 2.841 3 2.304 0.265 3
15 F 0.333 0.028 3 112.901 7.195 3 1.555 0.306 3
15 M 0.326 0.046 3 86.506 39.424 3 1.724 0.229 3
18 F 0.168 0.027 3 26.200 16.501 3 2.577 0.308 3
18 M 0.275 0.028 3 60.191 14.344 3 2.493 0.500 3
19 F 0.111 0.005 3 6.413 0.701 3 2.632 0.100 3
19 M 0.144 0.031 3 12.221 9.018 3 2.499 0.067 3
20 F 0.225 0.015 3 35.870 9.761 3 1.986 0.103 3
20 M 0.273 0.052 3 41.853 14.203 3 2.092 0.228 3
22 F 0.239 0.130 3 34.449 29.966 3 2.130 1.064 3
22 M 0.153 0.005 3 29.950 4.123 3 2.594 0.085 3
23 F 0.118 0.060 3 12.770 9.957 3 3.006 0.432 3
23 M 0.152 0.049 3 24.724 25.690 3 2.562 0.211 3
31 F 0.396 0.048 3 63.902 3.430 3 0.569 0.520 3
31 M 0.266 0.049 3 54.376 18.165 3 2.135 0.595 3
33 F 0.157 0.014 3 22.606 10.211 3 2.350 0.279 3
33 M 0.172 0.067 3 26.910 24.218 3 2.448 0.279 3
35 F 0.240 0.047 3 30.495 15.868 3 1.874 0.431 3
35 M 0.218 0.024 2 25.260 1.932 2 2.219 0.123 2
38 F 0.147 0.023 4 21.642 9.063 4 2.697 0.050 4
38 M 0.120 0.058 2 9.974 8.498 2 2.790 0.538 2
45 F 0.298 0.018 3 64.584 20.738 3 1.898 0.191 3
45 M 0.172 0.043 3 30.757 16.579 3 2.612 0.205 3
46 F 0.261 0.073 3 78.331 4.218 3 1.851 1.039 3
46 M 0.168 0.083 3 28.770 34.416 3 2.393 0.412 3
48 F 0.273 0.043 2 63.456 25.699 2 1.845 0.027 2
48 M 0.206 0.059 3 44.689 41.987 3 2.515 0.348 3
Tibial data.
Strain Sex TbN
(1/mm)
Std Dev
(1/mm)
N TbTh
(mm)
Std Dev
(mm)
N TbSp
(mm)
Std Dev
(mm)
N
4 F 5.092 0.111 3 0.077 0.009 3 0.203 0.016 3
4 M 5.221 0.327 3 0.072 0.007 3 0.192 0.016 3
5 F 5.604 0.406 3 0.078 0.001 3 0.173 0.014 3
5 M 4.943 0.218 3 0.074 0.004 3 0.212 0.008 3
10 F 5.128 0.068 2 0.075 0.001 2 0.204 0.001 2
10 M 5.221 0.139 3 0.076 0.008 3 0.209 0.009 3
15 F 6.208 0.223 3 0.074 0.003 3 0.153 0.013 3
15 M 6.003 0.365 3 0.081 0.002 3 0.166 0.017 3
18 F 4.995 0.459 3 0.075 0.003 3 0.223 0.012 3
18 M 5.690 0.060 3 0.084 0.006 3 0.181 0.007 3
19 F 4.632 0.448 3 0.077 0.011 3 0.235 0.011 3
19 M 4.796 0.228 3 0.079 0.004 3 0.210 0.004 3
20 F 5.254 0.489 3 0.082 0.002 3 0.209 0.010 3
20 M 5.080 0.292 3 0.093 0.022 3 0.203 0.006 3
22 F 4.832 0.454 3 0.082 0.006 3 0.207 0.027 3
22 M 4.929 0.438 3 0.069 0.004 3 0.217 0.021 3
23 F 4.748 0.175 3 0.065 0.011 3 0.220 0.011 3
23 M 5.019 0.488 3 0.068 0.003 3 0.214 0.036 3
31 F 5.407 0.248 3 0.098 0.003 3 0.186 0.007 3
31 M 5.467 0.292 3 0.077 0.003 3 0.173 0.017 3
33 F 5.079 0.224 3 0.073 0.002 3 0.199 0.016 3
33 M 5.114 0.133 3 0.073 0.007 3 0.198 0.014 3
35 F 4.769 0.123 3 0.084 0.006 3 0.221 0.008 3
35 M 4.941 0.004 2 0.087 0.012 2 0.209 0.006 2
38 F 4.832 0.268 4 0.072 0.010 4 0.208 0.006 4
38 M 5.021 0.345 2 0.067 0.005 2 0.208 0.017 2
45 F 5.521 0.200 3 0.076 0.000 3 0.183 0.014 3
45 M 5.451 0.321 3 0.072 0.011 3 0.199 0.011 3
46 F 5.094 0.179 3 0.071 0.015 3 0.192 0.017 3
46 M 5.216 0.385 3 0.073 0.002 3 0.209 0.030 3
48 F 5.784 0.368 2 0.073 0.002 2 0.171 0.015 2
48 M 5.234 0.468 3 0.072 0.002 3 0.199 0.026 3

Online Appendix 2: Genetic Correlations

Table A4.

Femoral genetic correlations with significant correlations in bold face

Area Ixx Iyy Rig My Mu d’ fx d’
py
E σult
Area 1.00
Ixx 0.78 1.00
Iyy 0.89 0.93 1.00
Rig 0.62 0.30 0.33 1.00
My 0.86 0.58 0.70 0.63 1.00
Mu 0.90 0.63 0.71 0.80 0.91 1.00
d’ fx -0.35 -0.34 -0.34 -0.31 -0.53 -0.40 1.00
d’ py -0.37 -0.38 -0.39 -0.18 -0.57 -0.38 0.97 1.00
E -0.23 -0.62 -0.54 0.49 -0.06 0.01 0.03 0.16 1.00
σult -0.07 -0.56 -0.40 0.40 0.25 0.23 -0.05 -0.01 0.79 1.00

Table A5.

Radial genetic correlations with significant correlations in bold face

Area Ixx Iyy Rig My Mu d’ fx d’
py
E σult
Area 1.00
Ixx 0.81 1.00
Iyy 0.89 0.62 1.00
Rig 0.64 0.57 0.67 1.00
My 0.70 0.60 0.72 0.92 1.00
Mu 0.72 0.61 0.73 0.93 0.98 1.00
d’ fx -0.04 0.24 -0.11 -0.32 -0.21 -0.25 1.00
d’ py -0.04 0.24 -0.12 -0.30 -0.22 -0.25 0.99 1.00
E -0.05 -0.24 0.15 0.63 0.53 0.53 -0.56 -0.54 1.00
σult -0.05 -0.25 0.10 0.54 0.54 0.56 -0.53 -0.53 0.91 1.00

Table A6.

Tibial genetic correlations with significant correlations in bold face

BV/TV ConnD SMI TbN TbTh TbSp
BV/TV 1.00
ConnD 0.86 1.00
SMI -0.88 -0.66 1.00
TbN 0.73 0.87 -0.55 1.00
TbTh 0.62 0.22 -0.67 0.12 1.00
TbSp -0.78 -0.89 0.59 -0.92 -0.14 1.00

Table A7.

Femoral (F) and radial (R) cross-bone genetic correlations with significant correlations in bold face

Area
(F)
Ixx
(F)
Iyy
(F)
Rig
(F)
My
(F)
Mu
(F)
d’ fx
(F)
d’
py
(F)
E
(F)
σult
(F)
Area (R) 0.77 0.62 0.65 0.66 0.65 0.76 -0.39 -0.33 -0.08 -0.07
Ixx (R) 0.60 0.59 0.60 0.53 0.49 0.56 -0.24 -0.20 -0.11 -0.17
Iyy (R) 0.74 0.55 0.62 0.61 0.63 0.74 -0.41 -0.36 -0.08 -0.03
Rig (R) 0.69 0.57 0.57 0.47 0.67 0.67 -0.39 -0.40 -0.21 -0.13
My (R) 0.72 0.55 0.60 0.49 0.64 0.70 -0.36 -0.35 -0.13 -0.06
Mu (R) 0.72 0.60 0.61 0.51 0.66 0.68 -0.41 -0.39 -0.16 -0.15
d’ fx (R) -0.22 -0.34 -0.27 0.20 -0.27 -0.18 0.37 0.44 0.50 0.29
d’ py (R) -0.22 -0.34 -0.28 0.21 -0.26 -0.18 0.37 0.43 0.51 0.29
E (R) 0.26 0.09 0.10 0.07 0.36 0.26 -0.23 -0.28 -0.11 0.02
σult (R) 0.25 0.10 0.11 0.06 0.31 0.23 -0.21 -0.24 -0.07 -0.01

Table A8.

Femoral (F) and tibial (T) cross-bone genetic correlations with significant correlations in bold face. The italicized value is not significant and is actually below r = ±0.35; it rounds up to the significance threshold value

Area
(F)
Ixx
(F)
Iyy
(F)
Rig
(F)
My
(F)
Mu
(F)
d’ fx
(F)
d’
py
(F)
E
(F)
σult
(F)
BV/TV (T) 0.53 0.41 0.45 0.41 0.40 0.44 -0.03 -0.02 0.07 -0.01
ConnD (T) 0.38 0.47 0.48 0.07 0.23 0.20 0.02 -0.02 -0.21 -0.27
SMI (T) -0.60 -0.43 -0.50 -0.45 -0.53 -0.53 0.17 0.17 -0.04 0.00
TbN (T) 0.23 0.40 0.35 0.08 0.13 0.12 0.08 0.06 -0.14 -0.25
TbTh (T) 0.55 0.23 0.30 0.62 0.49 0.52 -0.21 -0.16 0.28 0.14
TbSp (T) -0.35 -0.48 -0.48 -0.09 -0.18 -0.21 -0.10 -0.07 0.21 0.28

Table A9.

Radial (R) and tibial (T) cross-bone genetic correlations with significant correlations in bold face

Area
(R)
Ixx
(R)
Iyy
(R)
Rig
(R)
My
(R)
Mu
(R)
d’ fx
(R)
d’
py
(R)
E
(R)
σult
(R)
BV/TV (T) 0.37 0.47 0.29 0.38 0.46 0.37 0.11 0.11 0.04 0.07
ConnD (T) 0.17 0.39 0.06 0.24 0.28 0.22 0.01 0.00 -0.04 -0.03
SMI (T) -0.45 -0.50 -0.41 -0.45 -0.48 -0.43 -0.08 -0.08 -0.10 -0.09
TbN (T) 0.06 0.26 -0.01 0.10 0.05 0.05 -0.08 -0.07 -0.10 -0.11
TbTh (T) 0.53 0.33 0.55 0.58 0.55 0.58 -0.02 -0.02 0.41 0.41
TbSp (T) -0.18 -0.39 -0.09 -0.12 -0.19 -0.15 -0.08 -0.07 0.23 0.15

References

  1. Allison SJ, Herzog H. NPY and bone. In: Zukowska Z, Feuerstein GZ, editors. NPY Family of Peptides in Neurobiology, Cardiovascular and Metabolic Disorders: from Genes to Therapeutics. Birkhauser Verlag; Switzerland: 2006. pp. 171–182. [Google Scholar]
  2. Arya R, Blangero J, Williams K, Almasy L, Dyer TD, Leach RJ, O’Connell P, Stern MP, Duggirala R. Factors of insulin resistance syndrome--related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Mexican-Americans. Diabetes. 2002;51:841–847. doi: 10.2337/diabetes.51.3.841. [DOI] [PubMed] [Google Scholar]
  3. Baldock PA, Allison SJ, Lundberg P, Lee NJ, Slack K, Lin EJ, Enriquez RF, McDonald MM, Zhang L, During MJ, Little DG, Eisman JA, Gardiner EM, Yulyaningsih E, Lin S, Sainsbury A, Herzog H. Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis. Journal of Biological Chemistry. 2007;282:19092–19102. doi: 10.1074/jbc.M700644200. [DOI] [PubMed] [Google Scholar]
  4. Beamer WG, Shultz KL, Churchill GA, Frankel WN, Baylink DJ, Rosen CJ, Donahue LR. Quantitative trait loci for bone density in C57BL/6J and CAST/EiJ inbred mice. Mammalian Genome. 1999;10:1043–1049. doi: 10.1007/s003359901159. [DOI] [PubMed] [Google Scholar]
  5. Beamer WG, Shultz KL, Donahue LR, Churchill GA, Sen S, Wergedal JR, Baylink DJ, Rosen CJ. Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of mice. Journal of Bone & Mineral Research. 2001;16:1195–1206. doi: 10.1359/jbmr.2001.16.7.1195. [DOI] [PubMed] [Google Scholar]
  6. Brodt MD, Ellis CB, Silva MJ. Growing C57BL/6 mice increase whole bone mechanical properties by increasing geometric and material properties. Journal of Bone & Mineral Research. 1999;14:2159–2166. doi: 10.1359/jbmr.1999.14.12.2159. [DOI] [PubMed] [Google Scholar]
  7. Castro JP, Joseph LA, Shin JJ, Arora SK, Nicasio J, Shatzkes J, Raklyar I, Erlikh I, Pantone V, Bahtiyar G, Chandler L, Pabon L, Choudhry S, Ghadiri N, Gosukonda P, Muniyappa R, von-Gicyzki H, McFarlane SI. Differential effect of obesity on bone mineral density in White, Hispanic and African American women: a cross sectional study. Nutrition & Metabolism. 2005;2:9. doi: 10.1186/1743-7075-2-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chai CK. Analysis of quantitative inheritance of body size in mice. II. Gene action and segregation. Genetics. 1956;41:167–178. doi: 10.1093/genetics/41.2.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cheverud JM, Ehrich TH, Hrbek T, Kenney JP, Pletscher LS, Semenkovich CF. Quantitative trait loci for obesity- and diabetes-related traits and their dietary responses to high-fat feeding in LGXSM recombinant inbred mouse strains. Diabetes. 2004a;53:3328–3336. doi: 10.2337/diabetes.53.12.3328. [DOI] [PubMed] [Google Scholar]
  10. Cheverud JM, Ehrich TH, Kenney JP, Pletscher LS, Semenkovich CF. Genetic evidence for discordance between obesity- and diabetes-related traits in the LGXSM recombinant inbred mouse strains. Diabetes. 2004b;53:2700–2708. doi: 10.2337/diabetes.53.10.2700. [DOI] [PubMed] [Google Scholar]
  11. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New England Journal of Medicine. 1996;334:292–295. doi: 10.1056/NEJM199602013340503. [DOI] [PubMed] [Google Scholar]
  12. Currey JD. Effects of differences in mineralization on the mechanical properties of bone. Philosophical Transactions of the Royal Society of London - Series B: Biological Sciences. 1984;304:509–518. doi: 10.1098/rstb.1984.0042. [DOI] [PubMed] [Google Scholar]
  13. Dionne IJ, Garant MJ, Nolan AA, Pollin TI, Lewis DG, Shuldiner AR, Poehlman ET. Association between obesity and a polymorphism in the beta(1)-adrenoceptor gene (Gly389Arg ADRB1) in Caucasian women. International Journal of Obesity. 2002;26:633–639. doi: 10.1038/sj.ijo.0801971. [DOI] [PubMed] [Google Scholar]
  14. Ehrich TH, Kenney JP, Vaughn TT, Pletscher LS, Cheverud JM. Diet, obesity, and hyperglycemia in LG/J and SM/J mice. Obesity Research. 2003;11:1400–1410. doi: 10.1038/oby.2003.189. [DOI] [PubMed] [Google Scholar]
  15. Falconer DS, Mackay T. Introduction to quantitative genetics. John Wiley and Sons; New York: 1997. [Google Scholar]
  16. Fisher MC, Meyer C, Garber G, Dealy CN. Role of IGFBP2, IGF-I and IGF-II in regulating long bone growth. Bone. 2005;37:741–750. doi: 10.1016/j.bone.2005.07.024. [DOI] [PubMed] [Google Scholar]
  17. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nature Medicine. 1995;1:1311–1314. doi: 10.1038/nm1295-1311. [DOI] [PubMed] [Google Scholar]
  18. Goodale H. A study of the inheritance of body weight in the albino mouse by selection. Journal of Heredity. 1938;29:101–112. [Google Scholar]
  19. Goodale H. Progress report on possibilities in progeny test breeding. Science. 1941;94:442–443. doi: 10.1126/science.94.2445.442. [DOI] [PubMed] [Google Scholar]
  20. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269:543–546. doi: 10.1126/science.7624777. [DOI] [PubMed] [Google Scholar]
  21. Hamrick MW, Pennington C, Newton D, Xie D, Isales C. Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone. 2004;34:376–383. doi: 10.1016/j.bone.2003.11.020. [DOI] [PubMed] [Google Scholar]
  22. Hamrick MW, Della-Fera MA, Choi YH, Pennington C, Hartzell D, Baile CA. Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice. Journal of Bone & Mineral Research. 2005;20:994–1001. doi: 10.1359/JBMR.050103. [DOI] [PubMed] [Google Scholar]
  23. Hassa H, Tanir HM, Senses T, Oge T, Sahin-Mutlu F. Related factors in bone mineral density of lumbar and femur in natural postmenopausal women. Archives of Gynecology & Obstetrics. 2005;273:86–89. doi: 10.1007/s00404-005-0015-0. [DOI] [PubMed] [Google Scholar]
  24. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. Journal of the American Medical Association. 2004;291:2847–2850. doi: 10.1001/jama.291.23.2847. [DOI] [PubMed] [Google Scholar]
  25. Henry M, Ghibaudi L, Gao J, Hwa JJ. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors. Obesity Research. 2005;13:36–47. doi: 10.1038/oby.2005.6. [DOI] [PubMed] [Google Scholar]
  26. Hrbek T, de Brito RA, Wang B, Pletscher LS, Cheverud JM. Genetic characterization of a new set of recombinant inbred lines (LG/J x SM/J) formed from the intercross of SM/J and LG/J inbred mouse strains. Mammalian Genome. 2006;17:417–429. doi: 10.1007/s00335-005-0038-7. [DOI] [PubMed] [Google Scholar]
  27. Hubbard T, Andrews D, Caccamo M, Cameron G, Chen Y, Clamp M, Clarke L, Coates G, Cox T, Cunningham F, Curwen V, Cutts T, Down T, Durbin R, Fernandez-Suarez XM, Gilbert J, Hammond M, Herrero J, Hotz H, Howe K, Iyer V, Jekosch K, Kahari A, Kasprzyk A, Keefe D, Keenan S, Kokocinsci F, London D, Longden I, McVicker G, Melsopp C, Meidl P, Potter S, Proctor G, Rae M, Rios D, Schuster M, Searle S, Severin J, Slater G, Smedley D, Smith J, Spooner W, Stabenau A, Stalker J, Storey R, Trevanion S, Ureta-Vidal A, Vogel J, White S, Woodwark C, Birney E. Ensembl 2005. Nucleic Acids Research. 2005;33:D447–D453. doi: 10.1093/nar/gki138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Iorgi ND, Rosol M, Mittelman SD, Gilsanz V. Reciprocal relation between marrow adiposity and the amount of bone in the axial and appendicular skeleton of young adults. Journal of Clinical Endocrinology and Metabolism. 2008;93:2281–2286. doi: 10.1210/jc.2007-2691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Jehle PM, Schulten K, Schulz W, Jehle DR, Stracke S, Manfras B, Boehm BO, Baylink DJ, Mohan S. Serum levels of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-1 to -6 and their relationship to bone metabolism in osteoporosis patients. European Journal of Internal Medicine. 2003;14:32–38. doi: 10.1016/s0953-6205(02)00183-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Jepsen KJ, Akus OJ, Majeska RJ, Nadeau J. Hierarchical relationship between bone traits and mechanical properties in inbred mice. Mammalian Genome. 2003;14:97–104. doi: 10.1007/s00335-002-3045-y. [DOI] [PubMed] [Google Scholar]
  31. Jürimäe J, Jürimäe T. Adiponectin is a predictor of bone mineral density in middle-aged premenopausal women. Osteoporosis International. 2007;18:1253–1259. doi: 10.1007/s00198-007-0365-5. [DOI] [PubMed] [Google Scholar]
  32. Klein RF, Turner RJ, Skinner LD, Vartanian KA, Serang M, Carlos AS, Shea M, Belknap JK, Orwoll ES. Mapping quantitative trait loci that influence femoral cross-sectional area in mice. Journal of Bone & Mineral Research. 2002;17:1752–1760. doi: 10.1359/jbmr.2002.17.10.1752. [DOI] [PubMed] [Google Scholar]
  33. Koller DL, Schriefer J, Sun Q, Shultz KL, Donahue LR, Rosen CJ, Foroud T, Beamer WG, Turner CH. Genetic effects for femoral biomechanics, structure, and density in C57BL/6J and C3H/HeJ inbred mouse strains. Journal of Bone & Mineral Research. 2003;18:1758–1765. doi: 10.1359/jbmr.2003.18.10.1758. [DOI] [PubMed] [Google Scholar]
  34. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456–469. doi: 10.1016/j.cell.2007.05.047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Lenchik L, Register TC, Hsu F-C, Lohman K, Nicklas BJ, Freedman BI, Langefeld CD, Carr JJ, Bowden DW. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone. 2003;33:646–651. doi: 10.1016/s8756-3282(03)00237-0. [DOI] [PubMed] [Google Scholar]
  36. Li R, Svenson KL, Donahue LR, Peters LL, Churchill GA. Relationships of dietary fat, body composition, and bone mineral density in inbred mouse strain panels. Physiological Genomics. 2008;33:26–32. doi: 10.1152/physiolgenomics.00174.2007. [DOI] [PubMed] [Google Scholar]
  37. MacArthur J. Genetics of body size and related characteristics. I. Selection of small and large races of the laboratory mouse. American Naturalist. 1944;78:142–157. [Google Scholar]
  38. Margolis DS, Lien YH, Lai LW, Szivek JA. Bilateral symmetry of biomechanical properties in mouse femora. Medical Engineering & Physics. 2004;26:349–353. doi: 10.1016/j.medengphy.2003.11.002. [DOI] [PubMed] [Google Scholar]
  39. Mohan S, Libanati C, Dony C, Lang K, Srinivasan N, Baylink DJ. Development, validation, and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids. Journal of Clinical Endocrinology & Metabolism. 1995;80:2638–2645. doi: 10.1210/jcem.80.9.7545694. [DOI] [PubMed] [Google Scholar]
  40. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Journal of the American Medical Association. 2003;289:76–79. doi: 10.1001/jama.289.1.76. [DOI] [PubMed] [Google Scholar]
  41. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. Journal of the American Medical Association. 1999;282:1523–1529. doi: 10.1001/jama.282.16.1523. [DOI] [PubMed] [Google Scholar]
  42. Nguyen TV, Howard GM, Kelly PJ, Eisman JA. Bone mass, lean mass, and fat mass: Same genes or same environments? American Journal of Epidemiology. 1998;147:3–16. doi: 10.1093/oxfordjournals.aje.a009362. [DOI] [PubMed] [Google Scholar]
  43. National Osteoporosis Foundation . America’s bone health: the state of osteoporosis and low bone mass in our nation. National Osteoporosis Foundation; Washington: 2002. [Google Scholar]
  44. Panuccio V, Cutrupi S, Pizzini P, Mallamaci F, Tripepi G, Zoccali C. Neuropeptide Y and markers of osteoblast activity in dialysis patients: A cross-sectional study. American Journal of Kidney Disease. 2007;50:1001–1008. doi: 10.1053/j.ajkd.2007.09.001. [DOI] [PubMed] [Google Scholar]
  45. Perusse L, Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, Walts B, Snyder EE, Bouchard C. The human obesity gene map: the 2004 update. Obesity Research. 2005;13:381–490. doi: 10.1038/oby.2005.50. [DOI] [PubMed] [Google Scholar]
  46. Reid IR, Ames R, Evans MC, Sharpe S, Gamble G, France JT, Lim TM, Cundy TF. Determinants of total body and regional bone mineral density in normal postmenopausal women--a key role for fat mass. Journal of Clinical Endocrinology & Metabolism. 1992;75:45–51. doi: 10.1210/jcem.75.1.1619030. [DOI] [PubMed] [Google Scholar]
  47. Richards JB, Valdes AM, Burling K, Perks UC, Spector TD. Serum adiponectin and bone mineral density in women. Journal of Clinical Endocrinology and Metabolism. 2007;92:1517–1523. doi: 10.1210/jc.2006-2097. [DOI] [PubMed] [Google Scholar]
  48. Richman C, Baylink DJ, Lang K, Dony C, Mohan S. Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. Endocrinology. 1999;140:4699–4705. doi: 10.1210/endo.140.10.7081. [DOI] [PubMed] [Google Scholar]
  49. Rosen CJ, Bouxsein ML. Mechanisms of disease: is osteoporosis the obesity of bone? Nature Clinical Practice - Rheumatology. 2006;2:35–43. doi: 10.1038/ncprheum0070. [DOI] [PubMed] [Google Scholar]
  50. Sato S, Hanada R, Kimura A, Abe T, Matsumoto T, Iwasaki M, Inose H, Ida T, Mieda M, Takeuchi Y, Fukumoto S, Fujita T, Kato S, Kangawa K, Kojima M, Shinomiya K-I, Takeda S. Central control of bone remodeling by neuromedin U. Nature Medicine. 2007;13:1234–1240. doi: 10.1038/nm1640. [DOI] [PubMed] [Google Scholar]
  51. Semenkovich CF, Teitelbaum SL. Bone weighs in on obesity. Cell. 2007;130:410–411. doi: 10.1016/j.cell.2007.07.031. [DOI] [PubMed] [Google Scholar]
  52. Shinoda Y, Yamaguchi M, Ogata N, Akune T, Kubota N, Yamauchi T, Terauchi Y, Kadowaki T, Takeuchi Y, Fukumoto S, Ikeda T, Hoshi K, Chung UI, Nakamura K, Kawaguchi H. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. Journal of Cellular Biochemistry. 2006;99:196–208. doi: 10.1002/jcb.20890. [DOI] [PubMed] [Google Scholar]
  53. Sokal RR, Rohlf FJ. Biometry. W.H. Freeman and Company; San Francisco: 1995. [Google Scholar]
  54. Stewart KJ, Deregis JR, Turner KL, Bacher AC, Sung J, Hees PS, Tayback M, Ouyang P. Fitness, fatness and activity as predictors of bone mineral density in older persons. Journal of Internal Medicine. 2002;252:381–388. doi: 10.1046/j.1365-2796.2002.01050.x. [DOI] [PubMed] [Google Scholar]
  55. Tang Z-H, Xiao P, Lei S-Y, Deng F-Y, Zhao L-J, Deng H-Y, Tan L-J, Shen H, Xiong D-H, Recker RR, Deng H-W. A bivariate whole-genome linkage scan suggests several shared genomic regions for obesity and osteoporosis. Journal of Clinical Endocrinology and Metabolism. 2007;92:2751–2757. doi: 10.1210/jc.2006-2607. [DOI] [PubMed] [Google Scholar]
  56. Turner CH, Burr DB. Basic biomechanical measurements of bone: a tutorial. Bone. 1993;14:595–608. doi: 10.1016/8756-3282(93)90081-k. [DOI] [PubMed] [Google Scholar]
  57. Wan DC, Shi Y-Y, Nacamuli RP, Quarto N, Lyons KM, Longaker MT. Osteogenic differentiation of mouse adipose-derived adult stromal cells requires retinoic acid and bone morphogenetic protein receptor type IB signaling. Proceedings of the National Academy of Sciences. 2006;103:12335–12340. doi: 10.1073/pnas.0604849103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Wang Q, Bing C, Al-Barazanji K, Mossakowaska DE, Wang XM, McBay DL, Neville WA, Taddayon M, Pickavance L, Dryden S, Thomas ME, McHale MT, Gloyer IS, Wilson S, Buckingham R, Arch JR, Trayhurn P, Williams G. Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes. 1997;46:335–341. doi: 10.2337/diab.46.3.335. [DOI] [PubMed] [Google Scholar]
  59. Zhao L-J, Liu Y-J, Liu P-Y, Hamilton J, Recker RR, Deng H-W. Relationship of obesity with osteoporosis. Journal of Clinical Endocrinology and Metabolism. 2007;92:1640–1646. doi: 10.1210/jc.2006-0572. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES